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The myxovirus resistance gene (Mx1) has a broad spectrum of antiviral activities. It is therefore an interesting
candidate gene to improve disease resistance in farm animals. In this study, we report the use of somatic cell
nuclear transfer (SCNT) to produce transgenic pigs over-expressing the Mx1 gene. These transgenic pigs express
approximately 15–25 times more Mx1 mRNA than non-transgenic pigs, and the protein level of Mx1 was also
markedly enhanced. We challenged fibroblast cells isolated from the ear skin of transgenic and control pigs with
influenza A virus and classical swine fever virus (CFSV). Indirect immunofluorescence assay (IFA) revealed a profound
decrease of influenza A proliferation in Mx1 transgenic cells. Growth kinetics showed an approximately 10-fold
reduction of viral copies in the transgenic cells compared to non-transgenic controls. Additionally, we found that
the Mx1 transgenic cells were more resistant to CSFV infection in comparison to non-transgenic cells. These results
demonstrate that the Mx1 transgene can protect against viral infection in cells of transgenic pigs and indicate that
the Mx1 transgene can be harnessed to develop disease-resistant pigs.
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Type I interferons (IFNs) are important mediators of the
innate immune responses and are crucial for limiting the
early replication and spread of viruses [1]. An important
downstream effector of type I IFNs is the myxovirus re-
sistance gene (Mx1 in mice and pigs, MxA in humans).
The expression of Mx1 is strongly induced by IFN-α/β,
double-stranded RNA or viral infections [2,3]. The Mx1
protein can protect numerous hosts by preventing the
growth of a wide variety of viruses both in vitro and
in vivo including orthomyxoviruses [4-6], bunyaviruses
[7,8], rhabdoviruses [9], paramyxoviruses [10] and han-
taviruses [11,12]. Several studies showed that stably trans-
fected cells constitutively expressing chicken, mouse, pig
or human Mx1/MxA proteins effectively inhibited the
replication of several RNA viruses [13-19]. Specifically,
transgenic mice expressing mouse Mx1 or human MxA
also showed enhanced resistance to the influenza A virus* Correspondence: lai_liangxue@gibh.ac.cn
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unless otherwise stated.as well as to several other viruses [20,21]. Collectively,
these studies showed that the resistance of transgenic
mice to viral infection was not due to broad immuno-
logical activation in response to the virus. Rather, Mx1/
MxA proteins exert their antiviral effects by directly inhi-
biting replication of the viral genome.
Despite the potent antiviral activity of Mx1, its utility
to protect large animals, such as pigs, from viral infec-
tion has not yet been explored. Pigs are susceptible to
swine, human and avian influenza viruses. As alternate
hosts, pigs are believed to be “mixing vessels” by enabling
the genetic rearrangement of influenza viruses and thereby
amplify their genetic variation. As a consequence, the pro-
bability of influenza pandemics threatening humans is in-
creased [22]. A recent report revealed that the circulating
pandemic H1N1/2009 influenza A virus originated in pigs
and contained genetic contributions of human, avian and
swine influenza viruses [23]. Therefore, influenza resistant
pigs would not only benefit the livestock industry but also
global public health by eliminating a critical host so that
new variants of pandemic influenza strains can no longer
emerge. Mx1 is an interesting candidate gene to engi-
neer pigs with enhanced viral resistance. Besides influenza,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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swine infectious viruses such as CSFV. As the use of swine
vaccines to prevent these diseases is very costly, the pro-
duction of genetically modified pigs that possess congeni-
tal resistance to viral infection is an attractive avenue to
explore.
In this study we tested the hypothesis that Mx1 could
be used to generate pigs that resist viral infection. Pre-
viously, Mx1 transgenic pigs had been generated using
pronuclear injection. However, these animals failed to
express exogenous Mx1 protein [24]. SCNT technology
enables the efficient generation of genetically modified
large animals. The successful cloning and production of
genetically modified pigs by transferring nuclei of trans-
genic or gene targeted somatic cells have previously been
reported [25-27]. In this study, we produced transgenic
pigs over-expressing the Mx1 gene using the SCNT tech-
nology and explored its potency to protect porcine cells
from viral infection.
Materials and Methods
Vector construction and selection of transgenic donor cells
Fetal fibroblasts derived from Tibetan miniature pigs were
cultured in Dulbecco’s modified Eagle’s medium (DMEM,
HyClone, Logan, UT, USA) supplemented with 15% fetal
bovine serum (FBS, HyClone, Logan, UT, USA) and 1%
(v:v) penicillin/streptomycin (10,000 U/ml penicillin,
10,000 μg/ml streptomycin; GIBCO-BRL, Grand Island,
NY, USA) at 39°C in an incubator with 5% CO2. Cul-
tured fibroblasts were stimulated with 1000 U/ml IFN-α
(PeproTech, Rocky Hill, NJ, USA) for 6 hours. Total RNA
was extracted with TRIzol (Invitrogen, Carlsbad, CA,
USA) as described by the manufacturer. First strand
cDNA was synthesized by M-MLV Reverse Transcriptase
(Takara, Dalian, China). The following primers were used
to amplify the pig Mx1 gene by PCR based on reported
DNA sequence (gene ID: 397128): Mx1-F: 5’-TAATCTAG
AATGGTTTATTCCAGCTGTGAAAGTAAAG-3’, Mx1-
R: 5’-GCCAAGCTTGCCTGGGAACTTGGCGAGCC-3’.
The PCR product was digested using Xba I/Hind III and
ligated to the plasmid pBS-2A-enhanced green fluorescent
protein (EGFP) constructed by our lab to form the trans-
genic vector pMx1-2A-EGFP. In addition, the Mx1 gene
was cloned into the pVAX1 (Invitrogen, Carlsbad, CA,
USA) to construct the pVAX-Mx1 vector lacking the
fusion protein. This vector was used as a positive con-
trol in identifying the expressed protein products of
transgenic vector. The final constructs were confirmed
by sequencing. To test whether 2A could be used to dis-
criminate Mx1 and Mx1-EGFP proteins, 4 μg pMx1-
2A-EGFP, pVAX-Mx1 and empty vectors (pBS-2A-EGFP
and pVAX1) were transfected into the 293 T cells (106)
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
Cells were harvested and lysed 48 hours later. Equalamounts of total proteins were separated on a 10% po-
lyacrylamide gel and transferred to PVDF membrane
(Millipore, Bedford, MA, USA). The proteins were detec-
ted with mouse anti-Mx1 (1:500 dilution, ab79609; Abcam,
Cambridge, UK) and mouse anti-GAPDH (1:2000 dilution,
60004-1-Ig; Proteintech, Chicago, IL, USA) antibodies. A
horseradish peroxidase conjugated goat anti-mouse IgG
secondary antibody (1:2000 dilution, sc-2005; Santa Cruz,
CA, USA) and the ECL Plus detection system (Amersham
Pharmacia Biotech, Arlington Heights, IL, USA) was used
for visualization.
Primary pig fetal fibroblasts were isolated from a 25
day-fetus of a female Tibetan miniature pig. pMx1-2A-
EGFP was linearized with ApaLI and transfected into the
fibroblasts by electroporation (Gene Pulser Xcell, Bio-rad,
Hercules, CA, USA). The cells were split 1:10 into fresh
culture medium after transfection. After 48 hours, 1000
μg/ml G418 (Merck, Darmstadt, Germany) was added to
the medium to select transgenic cell colonies for approxi-
mately 2 weeks. The surviving cell colonies that expressed
EGFP were selected and propagated in a fresh 48-well
plate. Colonies that proliferated well were then expanded
and screened for the presence of the transgene. The posi-
tive colonies were frozen in small aliquots. Prior to SCNT,
Mx1-expressing transgenic cells were thawed and cultured
until they reached sub-confluence.
Production of Mx1 transgenic pigs
SCNT was performed as described [26]. The reconstruc-
ted embryos were then surgically transferred into the
oviduct of a surrogate female on the first day of standing
estrus. The pregnancy status was monitored using an ultra-
sound scanner between 30–35 days post-transplantation.
Some embryos were cultured for 6 days to test the blasto-
cyst formation rate as well as developmental ability.
Identification of transgenic pigs
Genomic DNA was extracted from the ear tissues of new-
born cloned pigs for PCR analysis. The following primers
were used to amplify the Mx1 gene fragments: Mx1-1: 5’-
CAAATGGAGTGCTGTGGTTG-3’, Mx1-2: 5’-GCAGTA
CACGATCTCCA-3’, Mx1-5: 5’- ACAGGAGCGACAATT
TTAAGC-3’ and Mx1-7: 5’- CGCCTTCACAGATGTTT
CAG-3’. The binding sites of these primers are shown in
Figure 1B. The expected sizes of PCR products of the
transgenic Mx1 and endogenous Mx1 genes differ due to
the presence of introns in the endogenous Mx1. Total
RNA was extracted from fibroblasts isolated from the ear
tissues of newborn cloned piglets using the RNeasy Mini
Kit (Qiagen, Valencia, CA, USA), subjected to reverse
transcription (PrimeScript RT Master Mix, Takara, Dalian,
China) and real time RT-PCR (SYBR Premix Ex Taq™,
Takara, Dalian, China) to determine the expression levels
of Mx1 mRNA. The expression values for the Mx1 mRNA
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Figure 1 Construction and expression of Mx1 transgenic vector. (A) Comparison of 2 alleles of Mx1 gene in Tibet miniature pigs (position
1675–1718 in nucleic acid sequence). The 3 base pair (bp)-deleted sequence is indicated with a dashed line. (B) Schematic diagram of the
transgenic vector pMx1-2A-EGFP and the binding sites of primers used in genomic PCR assays to screen for the presence of the transgene are
marked with arrows. The size of the PCR product using primers Mx1-2 and Mx1-7 is 192 bp. The same primers generate a PCR fragment of 575
bp from the endogenous genomic Mx1 due to the existence of an intron. The primer Mx1-5 is located in the 2A sequence and the transgenic
vector produces a 750 bp DNA fragment when amplified by PCR using primers Mx1-1 and Mx1-5. These primers cannot amplify wild-type
genomic DNA. (C) Schematic diagram of the Mx1 expression vector pVAX-Mx1. (D) Transient expression of pMx1-2A-EGFP and pVAX-Mx1 in 293
T cell. The arrowhead indicates the uncleaved transgenic Mx1-2A-EGFP protein. Arrow indicates the cleaved Mx1 protein.
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GAPDH. The following primers were used for real time
RT-PCR: Mx1-q1: 5’-CACAGAACTGCCAAGTCCAA-3’,
Mx1-q2: 5’-GCAGTACACGATCTGCTCCA-3’, GAPDH-
q1: 5’-CAGCAATGCCTCCTGTACCA-3’ and GAPDH-
q2: 5’-GATGCCGAAGTTGTCATGGA-3’. RNA samples
from 3 newborn natural breeding Tibet miniature piglets
were used as controls. Western blot were used to detect
the expression of Mx1 protein in the transgenic pigs as
described above using fibroblast lysates and organ lysates
of transgenic pig and non-transgenic pig control.
Determination of transgene copy numbers
Real time RT-PCR was performed to determine the inte-
grated transgene copy number by means of SYBR® PremixEx Taq™ II (Takara, Dalian, China). Genomic DNA of
transgenic and wild-type pigs was used in duplicate in
a 20 μl reaction using CFX96 Touch™ Real-Time PCR
Detection Sysctem (Bio-Rad, Hercules, USA). Primer se-
quences were designed as follow: gMx1-1: 5’-CCACATC
CCTCTGATCATCC-3’, gMx1-2: 5’-CAGGAGCCAGTCG
TATTGGT-3’, gGAPDH-1: 5’-CTTTGCCCCGCGATCT
AATG-3’ and gGAPDH-2: 5’-CTCACCCGTTCACTCCG
ACC-3’. Mx1 primers were designed to amplify the same
sequences in transgenic Mx1 and endogenous genomic
Mx1. Transgene copy number per individual was calcu-
lated by normalization to GAPDH. Since wild type pig has
2 copies of Mx1, transgene copy number of transgenic
pigs can be calculated based on the relative value to the
wild type pigs.
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Pig fibroblast cells were isolated from ear tissues of
transgenic and age-matched non-transgenic pigs. Tis-
sues were washed twice with PBS and finely chopped
(1–2 mm3) using scissors. Tissue pieces were then sus-
pended in DMEM supplemented with 15% FBS and 5%
(v/v) penicillin/streptomycin at 39°C in an incubator with
5% CO2. Cells migrated from the tissue pieces onto the
surface of the tissue culture dishes during the next few
days. The floating pieces of tissues were removed by aspir-
ation on day 5–6 of culture. When confluent, monolayers
of fibroblast-like cells were harvested with trypsin and
passaged in the medium described above.
Infection of transgenic fibroblasts with influenza A virus
Influenza A (H1N1) virus strain A/Puerto Rico/8/34 (PR8)
and H5N1 recombined strain NIBRG-14 (A/Vietnam/
1194/2004), were propagated in 7 day-old embryonated
chicken eggs. The allantoic fluid containing the virus
was collected and the viral titer was determined by a
plaque assay [28]. Fibroblasts from the Mx1 transgenic
pigs and non-transgenic controls were cultured in 24-
well plates. When confluent, cell monolayers were
infected with influenza A virus at a multiplicity of infec-
tion (MOI) of 1 plaque-forming unit (pfu) per cell. One
hour post-infection, non-internalized virus was dis-
carded by removal of the supernatant and cell mono-
layers were washed thoroughly with PBS. Then fresh
medium (DMEM containing 0.3% BSA and 0.5 μg/ml
TPCK-trypsin, Fluka, Buchs, Switzerland) was added to
the infected monolayers. 24 hours later, infected cells
were fixed in 4% paraformaldehyde containing 0.1%
Triton X-100 and then labeled with mouse anti-
influenza A nucleoprotein (NP) antibody (1:100 dilu-
tion, sc-80481; Santa Cruz, CA, USA) and stained with
Alexa Fluor 568-conjugated goat anti-mouse IgG second-
ary antibody (1:200 dilution). After washing in PBS, the
stained cells were examined by an inverted fluorescence
microscope. To quantify the number of positive cells, cells
were counted in more than 3 sections for each sample
using 10× microscopic fields to determine the percentage
of positive cells.
To accurately determine viral copies in the infected
cells, fibroblasts cultured in 24-well plates were infected
with influenza A virus PR8 and NIBRG-14 at an MOI of
1 and 0.01 pfu per cell, respectively (3 replicate wells for
each sample). We collected the supernatant of cultured
cells at 0, 5, 10, 15, 20, and 25 hours post-infection, ex-
tracted viral RNA from 200 μl of the cell culture su-
pernatant of each sample, and performed real time PCR
to identify the number of copies of the NP gene in
the supernatant. To generate a standard curve, the viral
NP gene was cloned into the pGEM-T vector (Promega,
Madison, WI, USA) and serially diluted to generatesamples containing 1-108 copies per ml of the plasmid.
Viral titers were calculated as the number of copies of
the NP gene per ml of viral supernatant and subsequently
converted to their log values using the standard curve
[29]. The primer Uni12, 5’-AGCAAAAGCAGG-3’ was
used to generate cDNA of all genes of the influenza
A virus; and primers NP-F, 5’-TGTATGGACCTGCCG
TAGC-3’ and NP-R, 5’-CCCTCTTGGGAGCACCTT-3’
were used to amplify the NP gene.
Infection of transgenic fibroblasts with CSFV
The highly virulent CSFV Shimen strain was obtained
from the Institute of Veterinary Drug Control, China.
Positive anti-CSFV serum and negative control serum
were prepared as described previously [30]. Freshly tryp-
sinized fibroblasts of the Mx1 transgenic pigs and
age-matched controls were added to 24-well plates
and incubated at 39°C in 5% CO2. When 80-90% conflu-
ent, cells were infected with the CSFV Shimen strain (400
TCID50 per well). At 60 hours post infection, the culture
media were aspirated and the cell monolayers in wells
were fixed with 80% cold acetone for 30 minutes, washed
3 times with PBS, and incubated for 1 h with pig anti-
CSFV serum (1:100 dilution) at 37°C in a humidified box.
Cells were then washed 3 times with PBS and incubated
with FITC-conjugated rabbit anti-pig IgG (1:60 dilution,
F4762; Sigma) for 1 hour. After thoroughly washing, posi-
tive cells were photographed and counted under an
inverted fluorescence microscope. The FITC fluorescence
of the secondary antibody stain could be observed clearly
using a 4 × objective lens and there was no interference of
the EGFP signal in the transgenic cells at this amplifica-
tion level.
Results
Generation of transgenic pigs over-expressing Mx1
We detected 2 isoforms of Mx1 mRNA in Tibet miniature
pigs. This is in accordance with previous studies reporting
a polymorphism in exon 13 of the porcine Mx1 gene [18].
One of the alleles has a 3 bp-deletion at position 1696–
1698 leading to the elimination of a serine residue at po-
sition 565 (Figure 1A). Both Mx1 isoforms were reported
to possess indistinguishable antiviral activities [18]. Previ-
ous reports also described a third isoform of porcine Mx1
characterized by an 11-bp deletion in exon 14 causing a
frameshift mutation in the carboxyl terminal region of the
Mx1 protein leading to an impairment of its antiviral
activities [18,31,32]. However, we did not detect this
isoform in the Tibet miniature pigs. Here we decided
to use the longest Mx1 isoform to construct transgenic
vectors. The plasmid was constructed by fusing the por-
cine Mx1 gene to an EGFP gene separate by a 2A pep-
tide linker (Figure 1B). EGFP was used as a reporter to
readily identify transgenic cells and pigs. The 2A peptide
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somal skipping mechanism [33]. However, as this peptide
is short, it exerts no adverse effects on the structure and
function of either the upstream or downstream proteins
[34,35]. Further, we constructed a vector that expressed
Mx1 without an EGFP fusion as a control for testing the
Mx1 expression in vitro (Figure 1C). Transient transfec-
tion of HEK293T cells showed that the majority of the
Mx1 could be efficiently separated from EGFP (Figure 1D).
However, a small amount of uncleaved fusion protein was
still detectable.
After transfection and selection, we selected three in-
dividual fetal fibroblast cell lines that expressed the Mx1
transgene as nuclear donors and transferred a total of
2283 SCNT embryos into 14 surrogate mothers that ex-
hibited natural estrus. Seven surrogates developed to
term and gave birth to 18 female piglets after 120-130
days of gestation. One piglet died at birth and two died
2 days after birth. A fourth piglet (#4-4 transgenic pig)
suffered a spine injury caused by the surrogate mother
during lactation. It died because of reduced body weight
gain at about 6 months of age. Fourteen piglets survived
to date (Table 1). Most live piglets appeared normal at
birth and there was no obvious difference in appearance
between the cloned and natural bred piglets.
PCR analysis of genomic DNA of each piglet showed
that 5 piglets were positive for the Mx1 transgene and all
of which had been derived from transgenic cell colony #4
(Figure 2A). Real time RT-PCR analysis revealed that
these transgenic piglets carried 5 copies of the transgene.
Additionally, we determined that Mx1 mRNA levels in
fibroblasts isolated from the 5 transgenic piglets were
15–25 times higher than in cloned piglets lacking the
transgene as well as in naturally bred piglets (Figure 2B).
Western blot showed enhanced Mx1 protein levels in fi-
broblasts isolated from transgenic pigs (Figure 2C). Mx1
protein levels were also elevated in the organs (heart, lung,
liver, muscle) of the deceased transgenic pig #4-4 as
compared to non-transgenic pigs (Figure 2D). We also ob-
served EGFP expression in fibroblasts and hooves ofTable 1 Summary of SCNT results for the generation of
Mx1 transgenic pigs
Nuclear donor cell lines #1 #2 #3
Embryos transferred to recipients 937 855 491
Recipients 6 5 3
Pregnancies 2 4 1
Pregnancies brought to term 2 4 1
Born piglets 7 6 5
Live piglets 5 5 4
Transgenic piglets 0 0 5all 5 transgenic piglets further illustrating the successful
generation of transgenic animals that robustly express the
Mx1 gene in a wide variety of tissues (Figure 3A, B, C).Fibroblasts isolated from Mx1 transgenic pigs are more
resistant to influenza A viral infection
Next we asked whether high expression levels of Mx1
rendered transgenic cells resistant to influenza A infec-
tion. To test this proposition, ear fibroblasts from trans-
genic pigs as well as non-transgenic controls were isolated
and challenged with two different strains of influenza A vi-
ruses, PR8 and NIBRG-14. After 24 hours, we monitored
infection by influenza A viruses using the IFA assay. We
observed that the replication of the 2 influenza A strains
was profoundly decreased in fibroblasts transgenic for
Mx1 (Figure 4). Next, we monitored the viral growth
curve by real time RT-PCR (Figure 5). When challenged
with PR8 virus at an MOI of 1, we observed substantially
lowered titers of PR8 virus in the transgenic versus the
non-transgenic cells (Figure 5A). When the viral titers
peaked at 15 hours post infection, there were approxi-
mately 10-fold less viral copies in the transgenic cells than
in the non-transgenic cells. Following the peak at 15 h,
viral titers began to decline, and this process occurred
more rapidly in the Mx1 transgenic cells than in the
non-transgenic controls. At 20 and 25 h post-infection,
there was a 101.5 to 102-fold difference in the number
of viral copies between the transgenic cells and the non-
transgenic cells (Figure 5A, B). Although cells infected at
an MOI of 0.01 produced overall lower viral titers than
at an MOI of 1, they exhibited similar viral replication
profiles and reduced viral copies in transgenic as com-
pared to control cells. Similar differences in the kinetics
of infection were observed between transgenic and non-
transgenic cells when the NIBRG-14 influenza strain was
used (Figure 5C, D).Fibroblasts isolated from Mx1 transgenic pigs are more
resistant to CSFV infection
Finally we wanted to study the inhibitory effects of the
Mx1 transgene on a virus other than influenza. To this
end, we infected fibroblast cells with CSFV and examined
its replication by detecting levels of the virus by IFA using
anti-CSFV serum. At 60 hours post-CSFV infection, the fi-
broblasts from non-transgenic controls exhibited bright
green fluorescence in the cytoplasm, indicating that most
cells were producing the virus (Figure 6). By contrast,
fewer cells from Mx1 transgenic pigs displayed green fluo-
rescence. We observed some variation between cells de-
rived from different pigs. Cells from pigs #4-1, #4-2, #4-4
displayed the lowest degree of green fluorescence, in-
dicating that the inhibitory effects on CSFV replication is
strongest in these cells (Figure 6).
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Figure 2 Genotyping and expression analysis of Mx1 transgene in trangenic pigs. (A) PCR to identify piglets with genomic integration of
the Mx1 transgene. Upper panel: PCR analysis with primers Mx1-2 and Mx1-7; Lower panel: PCR analysis with primers Mx1-1 and Mx1-5. The lanes
are: M, marker; N, non-transgenic pig; #4-1, #4-2, #4-3, #4-4, #4-5, transgenic pigs; P, plasmid DNA. (B) Identification of mRNA level of Mx1 in the
transgenic piglets using real time RT-PCR. Lanes 1–3 are naturally bred piglets, lanes 4–13 are cloned pigs without transgene integration, and
lanes 14–18 are 5 cloned pigs that contained the transgene. Porcine GAPDH was used as reference control. Values represent the mean ± s.d. from
triplicate experiments. Statistically significant P values are noted with an asterisk (*P < 0.001. One-way natural breeding pig was used to generate
the P values). (C) Detecting the presence of Mx1 protein in fibroblasts of transgenic pigs by western blot. Cell lysates from HEK293T cells transiently
transfected with pVAX-Mx1 were used as a positive control. (D) Expression of the Mx1 protein in various organs of transgenic and non-transgenic pigs.
The arrowhead indicates the uncleaved transgenic Mx1-2A-EGFP protein and the arrow indicates the cleaved Mx1 protein.
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Pigs are natural hosts for influenza A, CSFV and several
other viruses. To combat viral infections, the porcine
Mx1 gene has co-evolved with these viruses for thousands
of years to inhibit the viral life cycle. Even a virus withtremendous genetic plasticity cannot durably bypass this
innate resistance mechanism. All vertebrates possess be-
tween 2 and 3 IFN-inducible Mx-like genes. Mx proteins
from different species target alternative viruses, illustra-
ting the functional diversity of this protein family and its
A B C
Figure 3 Pictures of transgenic pigs and EGFP expression in the fibroblasts and hooves. (A) Picture of the 5 transgenic piglets taken at 1
month of age. (B) Expression of EGFP in ear fibroblasts isolated from a transgenic piglet; 20 × magnification. (C) Expression of EGFP in the hooves
of a transgenic piglet.
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Figure 4 Enhanced influenza A viral resistance in cultured fibroblasts isolated from transgenic pigs. (A) Ear fibroblasts isolated from Mx1
transgenic pigs and age-matched controls were infected with influenza A virus PR8 or NIBRG-14. After 24 hours, cells were fixed and stained for
NP expression (red: NP, blue: nuclei; 4 × magnification). (B) Quantification of NP-positive cells. Values represent the mean ± s.d., n = 3. *P < 0.01
compared with the non-transgenic group.
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Figure 5 Growth curves of influenza A viruses PR8 and NIBRG-14 in the isolated ear fibroblasts of Mx1 transgenic piglets. Growth
curves of PR8 at a MOI of 1 (A) and 0.01 (B). Growth curves of NIBRG-14 at a MOI of 1 (C) and 0.01 (D). Values represent the mean ± s.d., n = 3.
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ported that the pig Mx1 inhibits the replication of the
influenza A virus by blocking the endocytic cascade of in-
vading influenza A particles [37]. The pig Mx1 protein is
rapidly found in the cytoplasm in response to acute viral
infections [38-40]. Cells adjacent to infected tissues also
express Mx1 in vivo. Here we hypothesized, that if Mx1
would be expressed constitutively and ubiquitously in all
porcine cells, animals would be armed to promptly com-
bat and thus resist viral infections. Indeed, Su et al. [41]
produced transgenic fish over-expressing the fish Mx1
gene (GrMx), and these transgenic fishes exhibited in-
creased resistance to grass carp reovirus infection.
There is ample evidence, both in vivo and in vitro, that
pigs serve as facile hosts for the genetic reassortment of
influenza A viruses facilitating the evolution of genetically
novel viral strains [42-44]. These “new” influenza strains
can be generated in pigs that have been co-infected with
human, avian, and swine viruses. This phenomenon has
not only been confirmed by phylogenetic and epidemio-
logic analyses, but also by molecular studies that identified
hybrid viruses arising through genetic recombination
of diverse parental viruses within the porcine host cells.
Although influenza A viruses preferentially recognize cell
surface oligosaccharides with a terminal sialic acid, alter-
native entry routes do also exist. Most avian influenza
strains preferentially bind to the N-acetylneuraminic
acid-α2,3-galactose (NeuAcα2,3Gal) linkage on sialylo-
ligosaccharides, while human influenza strains prefer
the NeuAcα2,6Gal linkage. Cells of the upper respira-
tory tract in pigs often contain both NeuAcα2,6Gal and
NeuAcα2,3Gal sialyloligosaccharides [22]. This providesan environment that is conducive to co-infection with
human and avian influenza viruses and thus favors the
emergence of variant, potentially pandemic influenza A
strains. Additionally, 1 report has indicated that avian vi-
ruses that infected pigs but failed to replicate could still
contribute genetically to newly evolving viral strains [44].
Collectively, pigs afford many features that favor the
“mixing” of a variety of influenza strains, designating
the pig an alternate host that facilitates the dissemin-
ation and evolution of the influenza A virus.
Additionally, the CSFV leads to a highly contagious
disease of pigs. Outbreaks of CSFV infections usually leads
to significant economic losses in many countries world-
wide. Considering the broad-spectrum antiviral activities
of Mx1, we set out to test whether this gene could confer
multi-virus resistance in pigs and also prevent CSFV in-
fections. The inhibitory activity of Mx1 on CSFV had pre-
viously not been assessed.
In our experiments, we fused the Mx1 transgene to
the EGFP reporter to construct a transgenic vector in
which a 2A peptide could be used to discriminate be-
tween different fusions and endogenous Mx1. EGFP was
useful to facilitate the selection of transgenic cell col-
onies and to conduct the nuclear transfer. Transient ex-
pression of transgenic vector in HEK293T cells showed
that most of the fusion protein could be efficiently cleaved,
which encouraged us to produce transgenic pigs using this
vector. When the Mx1 transgenic pigs were born, we used
fibroblasts isolated from the ear tissues to evaluate the
antiviral activities of the Mx1 transgene in the pigs.
Ideally, epithelial cell from the respiratory tract should be
used to evaluate the protection from viral infection in
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Figure 6 Protective effect of Mx1 transgene against CSFV infection. (A) IFA and FITC conjugated antibodies were used to examine the viral
infection in fibroblasts from 5 transgenic and an age-matched non-transgenic pigs; 4 × magnification. (B) Quantification of CSFV-positive cells.
Values represent the mean ± s.d., n = 3. *P < 0.01 vs non-transgenic.
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http://www.cellregenerationjournal.com/content/3/1/11transgenic pigs. However, such cells are hard to obtain
without sacrificing the animal. We could detect higher
Mx1 expression levels in isolated fibroblasts at both
mRNA and protein levels. Encouragingly, we observed
an enhanced resistance to influenza A virus and CFSV
infection in the fibroblasts isolated from the Mx1 trans-
genic pigs as compared to non-transgenic pigs. Overall,
the influenza A virus replicates with only moderate effi-
ciency in pig fibroblasts as compared to other cell types(28% infected cells for PR8 and 16% infected cells for
NIBRG-14). Nevertheless, the presence of the Mx1 trans-
gene led to a further repression of the viral replication.
Collectively, we report for the first time the production
of transgenic pigs over-expressing the antiviral gene
Mx1. Clearly, further studies are needed to comprehen-
sively elucidate the antiviral activities of Mx1 transgenic
pigs. Nevertheless, the use of Mx1 transgenic pigs offers a
novel approach to explore avenues to prevent and control
Yan et al. Cell Regeneration 2014, 3:11 Page 10 of 11
http://www.cellregenerationjournal.com/content/3/1/11the evolution and the spread of pandemic influenza strains
or CSFV. The broad-spectrum antiviral properties of the
Mx1 gene may also provide resistance to other swine in-
fectious diseases, such as the porcine respiratory and re-
productive syndrome and foot-and-mouth disease. The
transgenic pigs produced in this study allow the testing of
a variety of swine viruses. These experiments would show
if transgenic Mx1 confers resistance to these viruses and
reveals the utility of these transgenic animals for the bet-
terment of global public health.
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